Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections are available in Scotland through the NHS and via private, regulated online pharmacies. The two licensed medicines are Mounjaro (tirzepatide) and Wegovy (semaglutide) — both prescription-only, both requiring a clinical assessment before a prescriber can approve treatment. Scotland sets its own access criteria for NHS weight management services, which differ from those in England, so the route you take depends on your circumstances and how long you are prepared to wait. Learning about these injections in detail is a sensible first step before you decide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The two licensed weight-loss injections available in the UK are Mounjaro and Wegovy. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist made by Eli Lilly. Wegovy contains semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. Both are given once a week as a subcutaneous injection using a pre-filled pen, and both work partly by slowing gastric emptying and reducing appetite signals.
The evidence base is substantial. In the SURMOUNT-1 trial, adults taking the highest tirzepatide dose achieved around 20–21% average body-weight reduction over 72 weeks. The STEP 1 trial for semaglutide 2.4 mg showed roughly 15% average reduction over 68 weeks. These are averages from thousands of participants, not promises, individual results vary, and both medicines work best alongside a reduced-calorie diet and increased activity, as NHS guidance on tirzepatide makes clear.
Something worth doing in the next minute: check the GPhC register at pharmacyregulation.org/registers before you order from any online pharmacy. A legitimate registered pharmacy will appear there instantly. If it does not, walk away.
Ozempic is also semaglutide, but it is licensed for type 2 diabetes rather than weight management, it is not an appropriate substitute, and treating it as one can create genuine clinical risk. The same applies to Rybelsus tablets, which are the diabetes formulation of oral semaglutide. For weight management, the medicines to ask about are Mounjaro and Wegovy.
In Scotland, NHS access to weight-loss injections runs through specialist weight management services and is governed by Scottish Medicines Consortium decisions and local health board commissioning, which means criteria and waiting times differ from those in England. NHS Inform Scotland provides guidance on diabetes and weight-loss medication relevant to Scottish patients, worth reading before your GP appointment. As a general principle, NHS eligibility requires a qualifying BMI and usually at least one weight-related condition, but the exact thresholds and waiting-list length vary by health board.
The NHS route is not fast for most people. Referrals go through your GP, are assessed at tier 3 or tier 4 services, and involve a multidisciplinary team including dietitians and specialist nurses. That level of support is genuinely valuable, but if your health board has a long list, or if you do not meet the current NHS criteria, a private route may be worth considering. Aberdeen-based patients and those in other Scottish cities face the same variability, and patients looking for weight loss injections in Sunderland will find that similar NHS access challenges apply across the border too.
For broader context on NHS eligibility across the UK, our page on how the three main weight-loss injections compare sets out the licensed options side by side.
A GPhC-registered online pharmacy can prescribe and dispense Mounjaro or Wegovy to eligible adults across Scotland, including rural and island communities where local specialist services may be a long drive away. The process works as follows: you complete a consultation, a GPhC-registered Independent Prescriber reads your answers and medical history the same day, and identity and weight are verified before anything is dispensed. A real clinician reviews your case; there is no automated approval.
At nume, orders placed before 12pm Monday to Friday are dispatched the same day once clinically approved, arriving by DPD the next working day in plain, unbranded packaging. One transparent price covers the consultation, prescription, medicine and delivery. There are no subscriptions and no auto-renewals, every repeat order is reviewed again by a prescriber. If you want to understand what private treatment typically costs, our page on how much weight loss injections cost sets out the full pricing picture honestly.
For patients who already use Mounjaro or Wegovy and are thinking about what to do around surgery, pregnancy or other medicines, our frequently asked questions page covers many of the situations our prescribers hear about most often.
The most common side effects of both medicines are gastrointestinal: nausea, loose stools, constipation, indigestion and occasionally vomiting. These tend to be most noticeable in the first few weeks or after a dose increase, and they generally ease as your body adjusts. Starting at the lowest dose and titrating gradually is how prescribers manage this, the first pen's job is to let your system adapt, not to produce dramatic weight loss immediately.
One side effect that warrants prompt medical attention is severe, persistent stomach pain that reaches into your back, with or without vomiting. The MHRA's Drug Safety Update from January 2026 highlighted acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines; if that symptom pattern develops, seek urgent help rather than waiting. You can report any suspected side effect, or a suspect seller, at the MHRA's Yellow Card scheme.
Women using hormonal contraception should know that tirzepatide can reduce absorption of the oral contraceptive pill, particularly in the first four weeks of treatment and after each dose increase. Adding a barrier method during those windows is the practical recommendation. Discuss any regular medicines with your prescriber at consultation, this is exactly the kind of detail a thorough clinical review covers.
Mounjaro and Wegovy are not recommended during pregnancy, whilst breastfeeding, or when trying to conceive. They are not licensed for anyone under 18. If any of those situations apply, tell your prescriber.
If you have questions about whether a particular health condition affects suitability, the interaction between weight-loss injections and specific conditions is explored in more detail elsewhere on the site. You are also welcome to get in touch with our team before starting a consultation.
Ready to find out whether you are eligible? Start your free consultation with our prescribers and get a same-day clinical review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.